TY  - GEN
AU  - Gupta,Kalpana
AU  - Hudgens,Michael
AU  - Corey,Lawrence
AU  - McElrath,M Juliana
AU  - Weinhold,Kent
AU  - Montefiori,David C
AU  - Gorse,Geoffrey J
AU  - Frey,Sharon E
AU  - Keefer,Michael C
AU  - Evans,Thomas G
AU  - Dolin,Raphael
AU  - Schwartz,David H
AU  - Harro,Clayton
AU  - Graham,Barney
AU  - Spearman,Paul W
AU  - Mulligan,Mark
AU  - Goepfert,Paul
TI  - Safety and immunogenicity of a high-titered canarypox vaccine in combination with rgp120 in a diverse population of HIV-1-uninfected adults: AIDS Vaccine Evaluation Group Protocol 022A
SN  - 1525-4135
PY  - 2002///0405
KW  - AIDS Vaccines
KW  - adverse effects
KW  - Adult
KW  - Double-Blind Method
KW  - Female
KW  - HIV Antibodies
KW  - blood
KW  - HIV Envelope Protein gp120
KW  - HIV Infections
KW  - diagnosis
KW  - HIV Seronegativity
KW  - immunology
KW  - HIV-1
KW  - Humans
KW  - Immunization Schedule
KW  - Male
KW  - Neutralization Tests
KW  - Recombinant Proteins
KW  - T-Lymphocytes, Cytotoxic
KW  - Vaccines, Combined
KW  - Vaccines, Synthetic
N1  - Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S
UR  - https://doi.org/10.1097/00126334-200203010-00005
ER  -